Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts

Journal of Vascular Surgery

Volumn 47, Issue 3, 2008, Pages 608-615

  Wong, Geoffrey ^a   Li, Jian ming ^a   Hendricks, Gregory ^a   Eslami, Mohammad H ^a   Rohrer, Michael J ^a   Cutler, Bruce S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF; PROTEIN C; THROMBOMODULIN;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERIOGRAPHY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DRUG INHIBITION; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SCANNING ELECTRON MICROSCOPY; STENT; SWINE; X RAY MICROANALYSIS;

ANGIOPLASTY, BALLOON; ANIMALS; CARDIOVASCULAR AGENTS; CAROTID ARTERY INJURIES; CAROTID STENOSIS; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; HUMANS; HYPERPLASIA; MALE; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; RECOMBINANT PROTEINS; SWINE; THROMBOMODULIN; TIME FACTORS;

EID: 39149094304     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.11.025     Document Type: Article

References (26)

1. Veith F.J., Gupta S.K., Ascer E., White-Flores S., Samson R.H., Scher L.A., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104-114
2. Quinones-Baldrich W.J., Prego A.A., Ucelay-Gomez R., Freischlag J.A., Ahn S.S., Baker J.D., et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 16 (1992) 209-217
3. Boyce B. Physical characteristics of expanded polytetrafluoroethylene grafts. In: Stanley J.C. (Ed). Biological and synthetic vascular prostheses (1982), Grune and Straton, New York 553-561
4. Ikada Y. Surface modification of polymers for medical applications. Biomaterials 15 (1994) 725-736
5. Bjorck. Thrombin uptake and inhibition on heparinized polytetrafluoroethylene (PTFE) grafts and native sheep vessels. Thromb Res 42 (1986) 605
6. Ebert C.D., Lee E.S., and Kim S.W. The antiplatelet activity of immobilized prostacyclin. J Biomed Mater Res 16 (1982) 629-638
7. Geary R.L., Koyama N., Wang T.W., Vergel S., and Clowes A.W. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 91 (1995) 2972-2981
8. Ito Y., Imanishi Y., and Sisido M. In vitro platelet adhesion and in vivo antithrombogenicity of heparinized polyetherurethaneureas. Biomaterials 9 (1988) 235-240
9. Ohshiro T., and Kosaki G. Urokinase immobilized on medical polymeric materials: Fundamental and clinical studies. Artific Organs 4 (1980) 58-64
10. Piao A.Z., Jacobs H.A., Park K.D., and Kim S.W. Heparin immobilization by surface amplification. ASAIO J 38 (1992) M638-M643
11. Ritter E.F., Fata M.M., Rudner A.M., and Klitzman B. Heparin bonding increases patency of long microvascular prostheses. Plast Reconstr Surg 101 (1998) 142-146
12. Senatore F., Bernath F., and Meisner K. Clinical study of urokinase-bound fibrocollagenous tubes. J Biomed Mater Res 20 (1986) 177-188
13. Esmon C.T., and Owen W.G. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A 78 (1981) 2249-2252
14. Esmon C.T. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9 (1995) 946-955
15. Jackman R.W., Beeler D.L., VanDeWater L., and Rosenberg R.D. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. Proc Natl Acad Sci U S A 83 (1986) 8834-8838
16. Suzuki K., Kusumoto H., Deyashiki Y., Nishioka J., Maruyama I., Zushi M., et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 6 (1987) 1891-1897
17. Wen D., Dittman W.A., Ye R.D., Deaven L.L., Majerus P.W., and Sadler J.E. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry (Mosc) 26 (1987) 4350-4357
18. Li J.M., Singh M.J., Nelson P.R., Hendricks G.M., Itani M., Rohrer M.J., et al. Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. J Surg Res 105 (2002) 200-208
19. Li J.M., Garnette C.S., Cahn M., Claytor R.B., Rohrer M.J., Dobson Jr. J.G., et al. Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin. J Vasc Surg 32 (2000) 804-813
20. Li J.M., Singh M.J., Itani M., Vasiliu C., Hendricks G., Baker S.P., et al. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg 39 (2004) 1074-1083
21. Verbeke G., and Lesaffre E. The linear mixed model: a critical investigation in the context of longitudinal data. In: Gregoire T. (Ed). Proceedings of the Nantucket Conference on Modeling Longitudinal and Spatially Correlated Data: Methods, Applications, and Future Directions (1997), Springer Verlag, New York 89-99
22. Littell R.C., Milliken G.A., Stroup W.W., and Wolfinger R.D. The SAS system for mixed models (1996), SAS Institute Inc, Cary, NC
23. Bailar III J.C., and Mosteller F. Medical uses of statistics (1992), The New England Journal of Medicine Books, Boston
24. Daniel W.W. Applied Nonparametric Statistics (1990), Chapman and Hall, PWS-Kent, Boston
25. Bui T.D., Gordon I.L., Nguyen T., Fujitani R.M., Wilson S.E., and Conroy R.C. Transluminal stenting for femoropopliteal occlusive disease: analysis of restenosis by serial arteriography. Ann Vasc Surg 20 (2006) 200-208
26. Ansel G.M., Botti Jr. C.F., and Silver M.J. The use of femoropopliteal stent grafts for critical limb ischemia. Techniques in vascular and interventional radiology 8 (2005) 140-145